Precision Medicine: Treatment Is More Effective With Combination Therapies

The old model of cancer treatments consisted of administering nonspecific cytotoxic therapies to various cancer patients. Now, cancer treatment has evolved to include agents that target a patient's genome and immune system, resulting in better patient outcomes. This 'precision medicine' approach individualizes treatment depending on each patient's unique tumor. Researchers discovered that using precision medicine to select combination treatments that target more than one genomic alteration is ef...

Continue reading

Do Industry Payments Serve Patient Interest?

National Cancer Institute (NCI)-designated cancer centers receive public funding that helps shape cancer care provided at the centers. Industry payments—financial compensation given to doctors by pharmaceutical companies—also play a role in shaping cancer care, although these payments do so more indirectly. Researchers used Open Payments—a system that tracks all industry payments made to doctors—in order to examine industry payments made to physician directors at NCIs. For this study, published ...

Continue reading

Copyright © 2022 Oncology Data Advisor. All rights reserved.